High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Food Allergy
Interventions
DIETARY_SUPPLEMENT

High dose

Patients will receive a high dose of sesame paste or flour (1200 mg of sesame protein) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product

DIETARY_SUPPLEMENT

Low dose

Patients will receive a low dose of sesame paste or flour (300 mg of sesame protein) mixed with apple mousse (supposing child tolerates apple). For the transparency of the study all patients will receive the same commercially prepared apple product

Trial Locations (1)

02-091

RECRUITING

Katarzyna Grzela, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER